IVIEW 1701
Alternative Names: IVIE-1701; IVIEW1701Latest Information Update: 15 Apr 2025
At a glance
- Originator IVIEW Therapeutics
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Inflammation; Pain